(Editor’s Note: The timing of this note is not ideal for reasons I explain in the postscript. Also, this is much longer than usual given the depth of the topic which is part of the reason for the delay.) Let me start with a disclaimer. This is not a prediction Continue Reading
AIG M&A Strategy: Dumb & Dumber
Well, I had something else almost ready to go for this week but that can wait because there’s some big insurance news to address. AIG announced two significant transactions last week – one for a 35% stake in Convex and the other for renewal rights to the much maligned Everest Continue Reading